E4112

Please Note: This trial is no longer enrolling new participants

Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment
Lehman CD;Gatsonis C;Romanoff J;Khan SA;Carlos R;Solin LJ;Badve S;McCaskill-Stevens W;Corsetti RL;Rahbar H;Spell DW;Blankstein KB;Han LK;Sabol JL;Bumberry JR;Gareen I;Snyder BS;Wagner LI;Miller KD;Sparano JA;Comstock C;
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Chou SS;Romanoff J;Lehman CD;Khan SA;Carlos R;Badve SS;Xiao J;Corsetti RL;Javid SH;Spell DW;Han LK;Sabol JL;Bumberry JR;Gareen IF;Snyder BS;Gatsonis C;Wagner LI;Wolff AC;Miller KD;Sparano JA;Comstock CE;Rahbar H;
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Slavkova KP;Kang R;Kazerouni AS;Biswas D;Belenky V;Chitalia R;Horng H;Hirano M;Xiao J;Corsetti RL;Javid SH;Spell DW;Wolff AC;Sparano JA;Khan SA;Comstock CE;Romanoff J;Gatsonis C;Lehman CD;Partridge SC;Steingrimsson J;Kontos D;Rahbar H;